Delirium with a fever could be an early marker of COVID-19, report researchers from the Universitat Oberta de Catalunya (UOC). The manifestation of this state of confusion, when accompanied by high fever, should be considered an early marker of the disease, particularly in the case of elderly patients, they argue.
Delirium is a state of confusion in which the person feels out of touch with reality, as if they are dreaming. We need to be on the alert, particularly in an epidemiological situation like this, because an individual presenting certain signs of confusion may be an indication of infection,
said UOC researcher Javier Correa.
Correa, together with UOC Cognitive NeuroLab researcher Diego Redolar Ripoll, has reviewed the body of scientific work published on the effects of COVID-19 in relation to the central nervous system, i.e. the brain. The review1 found that there are growing indications that the coronavirus also affects the central nervous system and produces neurocognitive alterations such as headaches and delirium, as well as psychotic episodes.
The main hypotheses that explain how the coronavirus SARS-CoV-2 affects the brain point to three possible causes: hypoxia or neuronal oxygen deficiency, inflammation of brain tissue due to cytokine storm and the fact that the virus has the ability to cross the blood-brain barrier to directly invade the brain,
He emphasized that any one of these three factors has the potential to result in delirium and explained that evidence of hypoxia-related brain damage has been observed in autopsies carried out on patients who have died from the infection and that it has been possible to isolate the virus from the cerebral tissue.
According to the researchers, delirium, cognitive deficits and behavioral anomalies are most likely to be the result of systemic inflammation of the brain and a state of hypoxia, which also causes the neuronal tissue to become inflamed in areas such as the hippocampus, which are associated with the cognitive dysfunctions and behavioral alterations presented by patients suffering delirium.
Javier C Vázquez, Diego Redolar-Ripoll. Delirium In Severe Acute Respiratory Syndrome-Coronavirus-2 Infection: A Point Of View Clinical Immunology and Immunotherapy (2020). DOI: 10.24966/CIIT-8844/1000039 ↩︎